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ABSTRACT: Bacterial growth inhibition tests have become a standard measure of
the adverse eﬀects of inhibitors for a wide range of applications, such as toxicity
testing in the medical and environmental sciences. However, conventional well-plate
formats for these tests are laborious and provide limited information (often being
restricted to an end-point assay). In this study, we have developed a microﬂuidic
system that enables fast quantiﬁcation of the eﬀect of an inhibitor on bacteria growth
and survival, within a single experiment. This format oﬀers a unique combination of
advantages, including long-term continuous ﬂow culture, generation of concentration
gradients, and single cell morphology tracking. Using Escherichia coli and the
inhibitor amoxicillin as one model system, we show excellent agreement between an
on-chip single cell-based assay and conventional methods to obtain quantitative
measures of antibiotic inhibition (for example, minimum inhibition concentration).
Furthermore, we show that our methods can provide additional information, over
and above that of the standard well-plate assay, including kinetic information on
growth inhibition and measurements of bacterial morphological dynamics over a wide range of inhibitor concentrations. Finally,
using a second model system, we show that this chip-based systems does not require the bacteria to be labeled and is well suited
for the study of naturally occurring species. We illustrate this using Nitrosomonas europaea, an environmentally important
bacteria, and show that the chip system can lead to a signiﬁcant reduction in the period required for growth and inhibition
measurements (<4 days, compared to weeks in a culture ﬂask).
Conventional bacterial growth inhibition tests have becomea standard measure of the adverse eﬀects of compounds
or materials on an aerobic organism. Such established protocols
are now widely used in pharmacological, environmental
monitoring, food safety, and wastewater toxicity investiga-
tions.1,2 However, these tests are time-consuming, are labor
intensive, and require large amounts of reagents (the standard
assay generally involves bacterial culture in a series of dilutions,
followed by measurement of bacterial number or metabolic
products).1 Since these assays are, in general, end-point
measurements, it is often diﬃcult to monitor the kinetics of
bacterial growth in situ or to retrieve other information such as
bacterial morphological changes.
Additional considerations also have to be given in areas
where wild type or naturally occurring species are of interest.
Outside of the laboratory, bacteria live in diverse environments
and their physiology is dependent on local conditions and the
species that they live in close contiguity with.3 Many of these
inﬂuences cannot be accommodated in conventional ﬂask or
microtiter well-based cultivation techniques.
Microﬂuidics oﬀers some clear advantages over these existing
formats, providing the possibility to develop high throughput,
real-time, low sample consumption assays for bacterial growth
tests.4−6 For example, in the context of screening antibiotic
toxicity, microdroplet based systems have already been
demonstrated by carrying out multiple functional assays with
minute samples (e.g., <100 μL).7,8 However, microdroplet
methods come with additional challenges, including the need
for highly sensitive optical readout systems in order to detect
low levels of signal (e.g ﬂuorescence) in small droplets moving
very fast.
An alternative method that appears more adaptable to a
microbiology laboratory is to track the growth of bacteria on a
microﬂuidic chip. Because of the nonadherent nature of many
bacteria, immobilization or trapping of bacteria on-chip is
necessary for time-lapse observations. The use of geometrical
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barriers, including microchannels,9,10 microchambers,11,12 sin-
gle cell tracks,13,14 and sandwiching a monolayer of bacteria
between an agar membrane and glass slide15 have all been
shown to be feasible. For growth and IC50 studies, most of
these methods still require oﬀ-chip preparation of a series of
dilutions and knowledge of potential conditions for the test,
which can be cumbersome for unknown systems.
It is now well established that generating concentration
gradients within a microﬂuidic system provides an eﬀective
means for evaluating a wide range of conditions in a single
experiment.16−20 In conjunction with time lapse tracking of
single cells, concentration gradient microﬂuidics has become an
eﬀective means for the study of cell migration (e.g chemo-
taxis).9,16,21−25 Surprisingly, its implementation for bacterial
growth inhibition tests is less well reported, perhaps because of
the diﬃculty of ﬁxing/retaining the bacteria on the chip.
Recently, Choi et al. developed a microﬂuidic agarose
channel system for trapping bacteria under a gradient of
antibiotics and illustrated its potential for fast evaluation of
antibiotic susceptibility.26 However, tracking the growth of
multilayer bacteria in a 3D gel is challenging and requires
specialized skills. Here, as an alternative, we describe a simple,
gradient microﬂuidic system for rapid bacterial growth
inhibition tests that is based on single bacterial morphology
tracking. It employs the simple assembly of a polydimethylsi-
loxane (PDMS) chip and a thin agarose membrane to establish
steady concentration gradients of inhibitors over a monolayer
of bacteria. Compared with previous studies, our system
enables long-term tracking of morphological dynamics of
individual bacteria under a wide range of inhibitor concen-
trations and thus allows fast evaluation of inhibition with both
quantitative and mechanistic information.
In this report we illustrate this method using two model
systems. First, with Escherichia coli (E. coli) and amoxicillin we
quantitatively compare the on-chip assay with conventional
laboratory-based dilution methods. Second, we evaluated the
capability of this on-chip approach for long-term cell studies
(∼4 days) on Nitrosomonas europaea, an environmentally
important nitriﬁcating bacteria. In this case, for the ﬁrst time,
we are able to show how the local microenvironment can have a
profound inﬂuence on investigations of bacteria such as these,
that have a complex natural habitat.
■ MATERIALS AND METHODS
Microﬂuidic Device. The microﬂuidic device developed in
this study comprises an assembly of a coverslip, a thin agarose
gel membrane, and a polydimethylsiloxane (PDMS) chip,
Figure 1a. The chip consists of two parallel channels at a
distance of 1 mm apart. The length, width, and depth
dimensions of each channel were 13 mm × 500 μm × 500
μm, respectively.
The thin agarose gel membrane was made from 2% agarose
(Sigma-Aldrich) in reverse osmosis (RO) water. The solution
was autoclaved, gelled, and stored at 4 °C prior to use. To
obtain a uniformly thick membrane, the gel was melted at 65
°C and cast between two clean coverslips separated by a 250
μm thick PDMS spacer. The assembly was sterilized with UV
light for 30 min and then left for 20 min to gell. After removal
of the top coverslip and the spacer, the membrane was slid onto
the channel side of an upturned PDMS chip.
To form a monolayer of bacteria, 3 μL of a bacterial
suspension (OD600 in the range of 0.05−0.08) was dispensed
onto the center of the agarose gel membrane and immediately
covered with a coverslip, Figure 1b. The assembly was clamped
in a plastic holder with spring loaded screws to ensure even
pressure distribution, Figure 1c. New agarose gel and coverslips
are used for each experiment to minimize contamination. The
rest of the device is reusable and after UV sterilization was
reassembled to perform repeated tests on fresh bacteria
samples.
Bacteria Culture. Culture of Escherichia coli (ATCC
25922) and Nitrosomonas europaea (ATCC25978) are
described in the Supporting Information.
On-Chip Inhibitory Test. On-chip inhibition tests were
conducted by delivering “source” and “sink” solutions through
parallel channels in the chip, Figure 1c. Solutions were
continuously delivered at a speed of 0.33 mm/s by a syringe
pump (NE-4000, Newera Pump Systems Inc.). The “source”
solution contained medium plus either 5 mg/L (E. coli) or 15
mg/L (N. europaea) amoxicillin, and the “sink” solution
contained medium alone. Shortly after delivery of the two
solutions, a steady concentration gradient was established via
diﬀusion through the agarose membrane to the bacterial
monolayer underneath. To visualize the time course and proﬁle
of the gradient formed, 30 μM ﬂuorescein (MW = 332.31,
Sigma-Aldrich) solution was used in a parallel set of (bacteria
free) experiments. All experiments were performed at room
temperature (21−22 °C), in line with a habitat temperature
commonly found for bacteria in the environment. At least three
replicate experiments were conducted for each of the
conditions reported below.
Oﬀ-Chip Inhibitory Test. Three replicate wells were ﬁlled
with 5 μL of bacterial suspension and 295 μL of LB broth, with
Figure 1. Conﬁguration of the three-layered microﬂuidic device: (a)
cross section of the device that consists of a glass substrate, a thin
agarose membrane, and a PDMS chip. A monolayer of bacteria were
trapped between the agarose layer and the glass substrate (not to
scale); (b) photograph of the assembled device in a plastic manifold.
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or without added amoxicillin (1, 2, 3, 4, and 5 mg/L). Plates
were placed on an orbital shaker (150 rpm, 22 °C) and the
OD600 recorded every 30 min for 12 h with a plate reader
(Synergy HT, Biotek).
Optical Image Acquisition and Analysis. Time-lapse
images were recorded using a motorized inverted microscope
equipped with a 40× objective lens (Zeiss AxioObserver Z1,
Photometrics Cascade II CCD) by observation through the
coverslip. All images were processed with Image J and
autocontrast was applied to bright ﬁeld images to give clearly
deﬁned cell edges. Bright ﬁeld images were processed and cell
areas calculated as described in the Supporting Information.
Calculation of Bacterial Growth Rate. Conventionally,
the growth rates of bacteria in suspension culture are
determined by
μ= = −R t tln ln(OD/OD ) ( )0 m (1)
where R is the increment ratio, OD0 and OD are the optical
density (OD600) of suspended cells (i.e., an indirect measure of
cell density as mass rather than numbers per unit volume)27,28
initially (t = 0) and after a time t; μ is the speciﬁc growth rate
(h−1), and tm is the lag period of bacterial growth.
For the on-chip culture, since bacteria grow as a non-
conﬂuent monolayer, cell mass in a colony can be considered to
be directly proportional to the colony’s area.15 Therefore this
can be used to analyze the growth rates of the bacteria within
the colony via the following equation.
μ= = −R S S t tln ln( / ) ( )0 m (2)
where S0 and S are the bacterial colony areas at the initial (t =
0) time and at time t. For on-chip measurements of bacterial
growth, estimations for a given concentration were made using
at least 10 randomly selected colonies.
■ RESULTS AND DISCUSSION
Characterization of Concentration Gradients. The
concentration gradient of amoxicillin in the device was
estimated by collecting ﬂuorescence images when ﬂuorescein
was used in place of amoxicillin in the source channel (note,
amoxicillin and ﬂuorescein have similar molecular weights and
consequently similar diﬀusion characteristics). Because of the
porous structure and high water content (98%) of agarose gel
membranes, diﬀusion leads to the concentration gradient of
ﬂuorescein (or amoxicillin) at the membrane/coverslip inter-
face being rapidly established, as shown in Figure 2a. Because of
the continuous ﬂow system used, the slight absorption of
ﬂuorescein (or other nonpolar small molecules) into the PDMS
chip does not signiﬁcantly aﬀect the concentration gradient
formed below the agarose layer.
Timelapse ﬂuorescence images recorded over a period of 6 h
showed that the intensity proﬁle changed by <10% after 20 min
(Figure 2b and Figure S1, Supporting Information). The
concentration proﬁles were readily derived from the intensity
proﬁles because of their excellent linear relationship (Figure S2,
Supporting Information). It should be noted, the concentration
at the source channel, where x = 0, was assumed to be the
maximum concentration of ﬂuorescein (Figure 2a). Further-
more, stable ﬂows (e.g., 0.33 mm/s) in the two channels were
found to be important to maintain the steady proﬁle
throughout the experiment. The concentration proﬁle of
ﬂuorescein at time 60 min served as a calibration curve to
calculate amoxicillin concentrations across the channel and was
acquired after each inhibitory test to validate the anticipated
concentration proﬁle. These calibrations showed that the
consistency of the chip assemblies and the distance/
concentration relationships varied by less than 5%.
Cell Growth On-Chip and In Well-Plates. The
continuous ﬂow culture formed in the microﬂuidic chip
provided constant nutrient supply and removal of metabolic
waste. Given the abundance of nutrients, bacterial cells were
able to grow exponentially within the monolayer, making it
possible to directly monitor single cell division and
morphologic variations in situ via simple bright ﬁeld microscopy
without resorting to complicated ﬂuorescence labeling eﬀorts
(e.g., fusing ﬂuorescence genes into cells).
Time-lapse images of E. coli cells were used to track their
growth during 5 h experiments. A typical example (Figure 3)
shows that cells growing underneath the (amoxicillin free) sink
channel proliferate readily. By optimizing the dispensing
conditions, bacteria were seeded as individuals, evenly
distributed as a monolayer between the agarose membrane
and coverslip. After a period of 2 h, colonies originating from
these single cells formed and expanded by cell division, with
continued growth leading to merging (5 h, Figure 3). The areas
that a cell and its colony occupied were calculated from time-
lapse images and used to derive individual cell growth rates.
The growth curves of E. coli cultured on-chip were compared
to those of conventional 96-well plate suspension cultures,
Figure S3, Supporting Information. Typically, the growth
curves in suspension culture showed no lag phase (tm = 0 h), an
exponential growth phase (until t = 3 h), and then a stationary
phase (t > 3 h). In the case of on-chip culture, after a short lag
phase (tm estimated to be 1.2 h), exponential growth was
observed and sustained for the duration of the experiment. It is
believed that the on-chip culture lag phase may be due to
Figure 2. Concentration gradient formed under the agarose layer in
the microﬂuidic chip: (a) bright ﬁeld (top) and ﬂuorescence (bottom)
images of the source and sink channels at time 20 min. The focal plane
was set by focusing at the interface between the agarose layer and the
coverslip surface; this ensured that the ﬂuorescence proﬁle accurately
corresponds to the concentration surrounding the bacteria. The
distance between the source (where x = 0) and the sink channel is 1
mm; (b) evolution of ﬂuorescein diﬀusion proﬁles during the ﬁrst 6 h
of microﬂuidic ﬂow. Inset shows the concentration gradient versus
distance at time 20 min.
Analytical Chemistry Article
dx.doi.org/10.1021/ac5001306 | Anal. Chem. 2014, 86, 3131−31373133
acclimatization of bacteria to their new environment, i.e., from
broth suspension to the surface of a glass substrate. Never-
theless, the speciﬁc growth rates μ, derived from the linear
slope of the growth curves, were 0.89 h−1 and 0.92 h−1 for the
on-chip and suspension culture, respectively. These are in good
agreement with each other, indicating that growth using the
two formats is directly comparable.
A key feature in the layered design of this microﬂuidic chip
that distinguishes it from other gradient microﬂuidic
devices16,26 is that the supply of nutrients and removal of
waste occurs at all points across the porous membrane. Thus,
bacteria can be kept growing in the exponential phase, without
being inhibited by metabolically produced toxins or waste
products. This provides a reliable means to perform
investigations that require continuous, long-term culture
without the undesirable inﬂuences of a stationary growth phase.
Inhibition Tests On-Chip and In Suspension. In on-chip
experiments, time-lapse, tiled images provide a means to
calculate the growth of bacteria exposed to the whole range of
amoxicillin concentrations generated within the gradient. For
example, in Figure 4a, E. coli at ﬁve diﬀerent locations
corresponding to ﬁve diﬀerent amoxicillin concentrations
(cAM) are shown. The concentration associated with each
frame corresponds to that at the center of the image (note:
each image is 110 μm × 100 μm).
Time-lapse images of the ﬁve locations clearly show that the
inhibitory eﬀects of amoxicillin on E. coli are both concentration
and time dependent, Figure 4a. For example, at t = 2 h, cell
growth was observed at all amoxicillin concentrations; at t = 4
h, elongation of cells (i.e., ﬁlamentation indicated by arrows in
the ﬁgure) was dominant at low concentrations cAM ≤ 2.0 mg/L
and cell dissolution (indicated with stars) occurred at high
concentrations (i.e., cAM ≥ 4.0 mg/L). This phenomenon
suggests that the elimination of E. coli with amoxicillin takes
time, and several stages are involved in the killing process (as
detailed in the next section).
The growth curves of E. coli at diﬀerent amoxicillin
concentrations are shown in Figure 4b. Below 2 mg/L
amoxicillin, an exponential growth phase is maintained,
indicating the antibiotic has negligible eﬀects. At 3 mg/L
amoxicillin and above, the inhibition of growth was observed.
At these higher concentrations, after an initial growth phase the
onset of decline in growth rate is dependent on the amoxicillin
concentration (higher concentrations lead to earlier loss of
bacteria). Similar relationships were observed with 96-well
plates, where E. coli growth was inhibited when the amoxicillin
concentration was above 2.0 mg/L (Figure S4, Supporting
Information).
The half maximal inhibitory concentration (IC50) is often
used to describe the eﬀectiveness of an inhibitor and can be
derived from sigmoidal ﬁtting of concentration−growth rates
(μ) curves (Figure 4c). It was found that the IC50 for
amoxicillin was 2.0 mg/L when using a 96-well plate and 2.5
mg/L for the on-chip system, showing a good agreement
between the two methods.
Similarly, the minimum inhibitory concentration (MIC), a
common measure in antibiotic susceptibility testing (AST), can
be readily interpolated from Figure 4c. Since MIC refers to the
minimum concentration of an antibiotic that gives total
inhibition, it can be derived from the point on the curves
where the speciﬁc growth rate approaches zero. The MIC of E.
coli to amoxicillin obtained from both on-chip and 96-well plate
assays was 3.0 mg/L. This is well within the range of 2−8 mg/L
reported by the Clinical and Laboratory Standard Institute.29
Considering the long period (usually 16−24 h) and tedious
dilutions involved in conventional AST measurements, the
microﬂuidic format demonstrated an advantageous speed that is
combined with a reliable performance.
Single Cell Morphological Dynamics in Response to
Amoxicillin Inhibition. Amoxicillin is one kind of β-lactam
antibiotic, which can inhibit the development of a bacterial cell
wall by interfering with transpeptidase enzymes responsible for
the formation of the cross-linkage between peptidoglycan
strands. In response to environmental pressures, for example,
antibiotic inhibition, bacteria can undergo diverse morpho-
logical changes in order to survive.30 Despite amoxicillin being
one of the most widely used antibiotics, little is known about its
detailed inﬂuence on single cell shape dynamics. In this study,
we demonstrate an application of using our microﬂuidic
systems for high-throughput tracking of single cell morpho-
logical dynamics under a wide range of antibiotic concen-
trations.
Our on-chip inhibition analysis of E. coli allows direct
correlation of single cell morphological variations with
amoxicillin concentrations and time scales. As shown in Figure
4a, during the initial growth period (0−2 h), ﬁlamentation of
cells was observed at each amoxicillin concentration.
Filamentation of E. coli under antibiotic treatment has been
reported previously12,15,30 and is regarded as a survival
mechanism. For some of the cells, a second stage, bulging,
the black dot in the middle of the ﬁlament body indicated by
the arrowhead in Figure 4a, occurs. These cells could be tracked
and with higher amoxicillin concentrations or prolonged
treatment, bulging cells underwent a ﬁnal lysis stage and left
faint residue on the surface. From numerous observations, it
was clear that the occurrence of each stage (ﬁlament−bulge−
lysis) is a hierarchical order and depends on the combination of
amoxicillin concentration and treatment periods. For example,
after the same period of treatment (e.g., 4 h) ﬁlamentation was
prevalent at lower concentrations (cAM ≤ 1 mg/L) whereas
more severe damage (i.e., bulge formation and lysis) was
dominant at higher concentrations (cAM ≥ 3 mg/L) (Figure
S5a, Supporting Information). The morphological variations of
E. coli were further conﬁrmed with high-resolution SEM images
of cells exposed to amoxicillin (Figure S5b, Supporting
Information).
Figure 3. Bacterial growth on-chip. Time-lapse images of monolayer
growth of E. coli during the ﬁrst 5 h of on-chip cultivation. Scale bars
10 μm.
Analytical Chemistry Article
dx.doi.org/10.1021/ac5001306 | Anal. Chem. 2014, 86, 3131−31373134
From this ﬁnding, we propose that variations of bacterial
length are a good measure to indicate diﬀerent stages during
the killing process. With the time-lapse images, we obtained
bacterial lengths over the full range of concentration gradients
of amoxicillin. For example, measurements at t = 4 h are shown
in Figure 5, where the x-axis indicates the distance of bacteria
from the source amoxicillin channel, the left y-axis is the
average length of bacteria at a distance “x”, and the right y-axis
is the corresponding concentration of amoxicillin. In relation to
the concentration gradient, bacterial lengths presented three
distinct clusters: (1) a ﬂat, low cell length region (between 0
and 1 mg/L), suggesting negligible changes and normal growth;
(2) a broad plateau region (between 1.5 and 3 mg/L) after a
step increase from region 1 suggesting elongation or
ﬁlamentation of cells. (Here, the relatively large deviation at
each data point shows the heterogeneity in resistance of
individual cells); and ﬁnally (3) a second ﬂat, lowest cell length
region (cAM ≥ 4 mg/L). This lowest cell length region is an
indication of total growth inhibition, and interestingly, the
lowest concentration in this region (4 mg/L) matches the MIC
valued obtained by conventional AST measurement well.31
Clearly, the use of bacterial length as a readout provides a vivid
illustration of both quantitative and mechanistic information of
the inhibitory eﬀect.
Beneﬁts for Long-Term Studies of Naturally Occur-
ring Bacteria. Wild type or bacteria in the environment are
often the subjects of interest. However, they are less known and
diﬃcult to study. To assess the applicability of our approach for
the investigation of these naturally occurring species, we carried
out a preliminary study on the inhibition of amoxicillin on N.
Figure 4. Inhibitory eﬀect of E. coli by amoxicillin: (a) time-lapse images of monolayers of bacterial cells exposed to diﬀerent concentrations of
amoxicillin during the ﬁrst 5 h of experiments (the horizontal black line in the 5 mg/L images is the edge of the source channel). Scale bars 10 μm.
(b) The growth curves of E. coli at diﬀerent concentrations. (c) Concentration and growth rates curves for on-chip (n = 10, randomly selected 10
colonies at the same concentration) and well plate tests. Sigmoidal ﬁtting was applied to the curves to derive an IC50. The standard deviation for
some data points on the 96-well plate curve are less than 4% of the average value, making the error bars invisible.
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europaea. As an ammonia oxidizing bacteria N. europaea plays a
central role in the global nitrogen cycle and in the elimination
of the damage of ammonia fertilizers and estrogen do to the
environment.32,33 However, they have proved diﬃcult to study
via conventional cultivation methods because of their slow
proliferation rate and sensitivity to variations in their
environments.34
Time lapse tracking of the growth of N. europaea on-chip was
carried out for 4 days. As shown in Figure S6, Supporting
Information, N. europaea are small rod-like bacteria and tend to
clump together. Similar to E. coli growth on-chip, a continuous
exponential growth was observed after a lag period (tm = 20 h)
with the speciﬁc growth rate, μ, being 0.05 h−1, Figure 6. In
contrast, several stages of growth rates were found in
conventional ﬂask culture (Figure 6). Interestingly, the initial
ﬂask growth rate (<12 h) is 0.05 h−1, similar to that found on-
chip. After that, a very signiﬁcant reduction of growth was
observed until it reached a steady value of 0.08 day−1 after ∼4
days. This reduction in rate may well reﬂect the fact that
ammonia-oxidizing bacteria such as N. europaea can be
inhibited by their own product, nitrite.34 In a closed ﬂask
culture, this nitrite accumulates, whereas in the environment,
such an inhibition can be removed by the presence of nitrite-
oxidizing bacteria living in close spatial contiguity.35 It is
possible that the continuous ﬂow culture “mimics” the
bacteria’s natural habitat by removing nitrite and thereby
minimizing its inhibition. This function of the chip system is of
signiﬁcant beneﬁt in long-term cell studies, where a stable
interference-free microenvironment is essential.
Following successful cultivation of N. europaea on-chip for 2
days, with the bacteria in an exponential growth phase, an
amoxicillin inhibition test was begun. As shown in Figure 7, cell
division and generation persisted at the highest concentrations
tested (15 mg/L, indicated by arrows in Figure 7), even after
exposure for 40 h; no variations in cell length and morphogies
were observed. The observed growth at such a high
concentration suggests N. europaea is resistant to amoxicillin.36
In comparison with the weeks of culture and laborious
spectrophotometric analysis needed for such inhibition
evaluations in ﬂask,37 our approach provides a well controlled
microenvironment that enables fast, reliable method for
“challenging” bacteria.
■ CONCLUSIONS
We have developed a microﬂuidic platform that enables long-
term continuous culture, generation of steady concentration
gradients, and single cell tracking. The platform provided a fast
and reliable means for both quantitative and mechanistic
investigations of bacterial inhibitors.
With E. coli and amoxicillin as a model system, we showed an
excellent agreement between on-chip single cell based assay
with conventional methods on quantitative measures (i.e., IC50
and MIC) of antibiotic inhibition. Furthermore, we show that
our methods provide rich information on bacterial morpho-
logical dynamics over a wide range of concentrations. For the
ﬁrst time, we illustrate the use of bacterial length as a read-out
together with knowledge of the concentration gradient to
provide quantitative information about an inhibitor’s eﬃcacy.
Most importantly, our system does not need labeling of the
bacteria and provides a novel, eﬀective means for bacterial
growth inhibition tests, especially for investigations of slowly
growing bacteria, such as N. europaea, and could be applied to
studies of single cell variability or exposure to a range of
environmental pressures.
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